Skip to main content
Molecular Medicine logoLink to Molecular Medicine
. 2025 Sep 6;31:286. doi: 10.1186/s10020-025-01359-3

Correction: Mucosal implications of oral Jak3-targeted drugs in COVID patients

Narendra Kumar 1,, Daniel Segovia 1, Priyam Kumar 2, Hima Bindu Atti 1, Soaham Kumar 3, Jayshree Mishra 1,
PMCID: PMC12413737  PMID: 40914794

Correction: Molecular Medicine 31, 203 (2025)

https://doi.org/10.1186/s10020-025-01260-z

In the sentence beginning ‘More notably, the strong link between …. disease (Satarker et al. 2021).’ the term “SARS-CoV-2” is written as “SARS-Cov-2” in the section Tyrosine kinases in viral entry and replication of this article [1].

The corrected sentence should read as "More notably, the strong link between ACE2 & JAK-STAT signaling throughout the COVID-19 disease analysis was directly demonstrated by the above relationship involving ACE2 & IFN-JAK-STAT signaling being confirmed in a separate cell related to SARS-Cov and SARS-CoV-2 disease (Satarker et al. 2021)."

The original article has been corrected.

Contributor Information

Narendra Kumar, Email: narendra08@tamu.edu.

Jayshree Mishra, Email: Jayshree.mishra@tamu.edu.

References

  • 1.Kumar N, Segovia D, Kumar P, et al. Mucosal implications of oral Jak3-targeted drugs in COVID patients. Mol Med. 2025;31:203. 10.1186/s10020-025-01260-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES